VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectivesMohammad Malekan, Armaghan Kazeminejad, Mohammad Ali Ebrahimzadeh et al.|Life Sciences|2024Cited by 44
Successful treatment of actinic prurigo with baricitinib in an 8‐year‐old child: A case reportMohammad Malekan, Nasim Gholizadeh, Nessa Aghazadeh et al.|Pediatric Dermatology|2024Cited by 7
JAK inhibitors as a promising therapy for immune-mediated photodermatosesMohammad Malekan, Ghasem Rahmatpour Rokni, Saeid Taghiloo et al.|Drug Discovery Today|2025Cited by 5
Efficacy and safety of baricitinib versus azathioprine, both combined with topical corticosteroids, in patients with moderate-to-severe atopic dermatitis: a single-centre randomized open-label trialMohammad Malekan, Parmida Gouran, Nasim Gholizadeh et al.|British Journal of Dermatology|2025Cited by 1
Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trialGhasem Rahmatpour Rokni, Nasim Gholizadeh, Mohammad Malekan et al.|Lasers in Medical Science|2025Cited by 0